Stock ScreenerStock IdeasHigh Risk, High Reward
High Risk, High Reward Stocks
Speculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!

Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
Ticker
Company
Zen Rating
Price
Value
Graham Fair Value
Graham Fair Value %
P/E
Forward P/E
P/S
P/B
PEG
Free Cash Flow
Free Cash Flow Yield
Book Value
BVPS
EV
EV/EBITDA
KALA
KALA BIO INC
$0.40N/AN/A-0.07x-0.45xN/A-0.38xN/A-$32.12M-1,128.71%-$8.67M-1.23$12.16M-0.40
PSTV
PLUS THERAPEUTICS INC
$0.30N/AN/A-0.18x-1.80x6.12x8.16xN/A-$15.75M-49.00%$5.05M0.05$27.96M-1.71
FBLG
FIBROBIOLOGICS INC
$0.26N/AN/A-0.63x-0.75xN/A2.89xN/A-$16.66M-141.83%$6.16M0.14$15.29M-0.87
NRXP
NRX PHARMACEUTICALS INC
$1.91N/AN/A-0.81x14.98x173.64x-2.08xN/A-$12.50M-29.42%-$25.76M-1.16$56.89M-1.50
RCKT
ROCKET PHARMACEUTICALS INC
$4.33N/AN/A-1.92x-2.80xN/A1.49xN/A-$202.79M-41.99%$313.67M2.81$415.82M-1.82
NAKA
NAKAMOTO INC
$0.26N/AN/A-0.23x-50.39x25.70x0.24xN/A-$17.47M-33.46%$477.56M2.35$292.40M-3.26
SLE
SUPER LEAGUE ENTERPRISE INC
$3.63N/AN/A-0.01x-0.46x0.03x-1.52xN/A-$10.33M-3,131.02%-$2.01M-22.07$5.29M-0.49
RVPH
REVIVA PHARMACEUTICALS HOLDINGS INC
$0.22N/AN/A-0.48x-0.71xN/A5.59xN/A-$27.90M-173.76%$4.55M0.06$12.24M-0.54
OSTX
OS THERAPIES INC
$1.38N/AN/A-1.68x-3.13xN/A13.36xN/A-$12.88M-29.20%$3.64M0.11$46.72M-2.59
PDSB
PDS BIOTECHNOLOGY CORP
$0.71N/AN/A-0.86x-1.02xN/A3.67xN/A-$32.28M-97.18%$9.45M0.20$26.50M-0.82
ACET
ADICET BIO INC
$7.41N/AN/A-0.37x-0.61xN/A0.65xN/A-$100.36M-237.91%$109.14M19.17$54.51M-0.52
ENLV
ENLIVEX LTD
$1.10N/AN/A-2.00x-3.37xN/A1.53xN/A-$11.06M-41.82%$17.48M0.73$8.52M-0.59
SGMO
SANGAMO THERAPEUTICS INC
$0.47N/AN/A-1.04x-1.67x4.35x25.33xN/A-$76.40M-53.40%$6.24M0.02$153.05M-1.51
SNTI
SENTI BIOSCIENCES INC
$0.95N/AN/A-0.29x-0.66xN/A3.06xN/A-$50.27M-202.86%$8.12M0.31$39.18M-0.90
IFRX
INFLARX NV
$0.93N/AN/A-1.34x-1.35x934.00x1.20xN/A-$49.57M-78.27%$52.75M0.78$56.91M-1.24
GUTS
FRACTYL HEALTH INC
$0.51N/AN/A-0.22x-0.72xN/A-21.82xN/A-$86.81M-265.42%-$3.18M-0.05$53.87M-0.45
TVRD
TVARDI THERAPEUTICS INC
$3.85N/AN/A-0.45x-1.84x8.97x1.30xN/A-$21.86M-60.55%$27.87M2.97$14.93M-1.71
HUMA
HUMACYTE INC
$1.16N/AN/A-5.04x-2.55x116.00x-45.72xN/A-$106.40M-57.93%-$4.75M-0.03$248.11M-13.14
VNRX
VOLITIONRX LTD
$0.24N/AN/A-1.06x-1.99x17.36x-0.86xN/A-$19.77M-75.31%-$34.64M-0.32$40.90M-1.94
TNYA
TENAYA THERAPEUTICS INC
$0.60N/AN/A-0.78x-1.28xN/A1.21xN/A-$73.47M-74.75%$82.87M0.51$55.45M-0.67
HOWL
WEREWOLF THERAPEUTICS INC
$0.64N/AN/A-0.40x-0.43xN/A1.05xN/A-$63.64M-217.03%$29.61M0.65$1.76M-0.03
INTZ
INTRUSION INC
$0.90N/AN/A-2.00x-2.80x2.47x1.84xN/A-$9.35M-52.00%$9.81M0.49$17.16M-2.75
ACRV
ACRIVON THERAPEUTICS INC
$1.68N/AN/A-0.79x-0.87xN/A0.41xN/A-$68.07M-105.06%$128.60M3.34$20.39M-0.26
RANI
RANI THERAPEUTICS HOLDINGS INC
$1.35N/AN/A-1.71x-4.90x51.92x-20.87xN/A-$27.78M-44.30%-$7.86M-0.17$177.45M-8.15
CTSO
CYTOSORBENTS CORP
$0.71N/AN/A-3.95x-0.25x1.30x4.95xN/A-$10.02M-22.50%$9.02M0.14$62.21M-7.31
HOVR
NEW HORIZON AIRCRAFT LTD
$1.97N/AN/A-2.81x-3.50xN/A8.25xN/A-$7.96M-9.59%$10.56M0.25$69.45M-3.10
CAN
CANAAN INC
$0.53N/AN/A-1.10x-2.12x0.64x0.81xN/AN/AN/A$437.37M0.69$327.73MN/A
CABA
CABALETTA BIO INC
$3.49N/AN/A-1.38x-1.93xN/A2.41xN/A-$120.26M-35.79%$139.47M1.45$301.54M-2.07
PALI
PALISADE BIO INC
$1.90N/AN/A-0.90x-4.57xN/A88.14xN/A-$10.08M-71.00%$3.21M0.43$278.06M-25.05
HELP
CYBIN INC
$7.69N/AN/A-2.11x-1.71xN/A1.90xN/A-$87.66M-26.81%$201.42M4.74$240.21M-2.49
CRVO
CERVOMED INC
$4.39N/AN/A-1.51x-2.27x6.59x1.56xN/A-$24.93M-61.37%$26.01M2.81$31.18M-1.22
BIOX
BIOCERES CROP SOLUTIONS CORP
$0.55N/AN/A-0.62x-3.37x0.11x0.13xN/A$46.51M133.82%$258.67M4.09$277.72M9.57
APRE
APREA THERAPEUTICS INC
$0.88N/AN/A-0.41x-0.81x11.36x0.51xN/A-$13.44M-241.14%$10.91M1.71-$8.24M0.60
DEFT
DEFI TECHNOLOGIES INC
$0.71N/AN/AN/A2.60xN/A3.28xN/AN/AN/A$83.09M0.24$197.83MN/A
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.